Biopharma mRNA, executive director global regulatory affairs
Case study
The overview
A leading biopharmaceutical company focused on researching, developing, and producing novel drugs based on the natural molecule, messenger RNA (mRNA), needed our support to find an executive director of global regulatory affairs. Their R&D is focused on innovative cancer immunotherapies, molecular therapies and prophylactic vaccines including Covid-19.
The challenge
Our partner needed someone highly experienced to progress the novel vaccine and therapeutic programs through preclinical and clinical development. This person had to able to represent regulatory affairs in cross-disciplinary areas with ideas to create and implement highly qualitative strategies for the development of their innovative products.
The solution
We were successfully able to identify qualified individuals on our internal database, as well as finding new talent via LinkedIn and network referrals. After detailed qualification of the candidate’s skills, we were able to shortlist four individuals and submit them to the organization. After initial telephone interviews, two of them were invited into our Frankfurt office and went through an interview process with 8 different SVPs and VPs.
The outcome
The project was completed inside 2 months with all stakeholders participating fully. The new executive director of global regulatory affairs was hired and started in August 2020.